Trevor Resnick
Neurology with Special Qualifications in Child Neurology · Miami, FLNPI 1780641381
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $148,655 of the $229,588 with a category attached, or 64.7%. 35 manufacturers reported payments, led by Eisai Inc. at 40.9% of the total. Reporting peaked in 2019 at $110,271 and has fallen 94.4% since, to $6,153 in 2025. Among neurology with special qualifications in child neurology clinicians in FL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 732 payments — averaging $313.64 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Eisai Inc.$94K
- UCB, Inc.$35K
- Mallinckrodt Enterprises LLC$28K
- Sunovion Pharmaceuticals Inc.$19K
- Mallinckrodt Hospital Products Inc.$12K
- Catalyst Pharmaceuticals, Inc.$8K
- plus $33K from 29 others
Across 15 payments — averaging $5589.25 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Eisai Inc.$84K
What the payments were for
- Consulting fees$47,27821%
- Speaking & faculty fees$148,65565%
- Travel & lodging$19,0248%
- Food & beverage$14,6046%
- Education$270%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Eisai Inc. | 119 | $93,948 |
| UCB, Inc. | 130 | $35,380 |
| Mallinckrodt Enterprises LLC | 27 | $27,714 |
| Sunovion Pharmaceuticals Inc. | 61 | $19,219 |
| Mallinckrodt Hospital Products Inc. | 6 | $11,508 |
| Catalyst Pharmaceuticals, Inc. | 12 | $8,392 |
| Supernus Pharmaceuticals, Inc. | 92 | $7,954 |
| SK Life Science, Inc. | 25 | $5,281 |
| UCB SA | 10 | $4,959 |
| Aquestive Therapeutics, Inc. | 21 | $3,288 |
| Hikma Pharmaceuticals USA | 2 | $3,000 |
| Azurity Pharmaceuticals, Inc. | 5 | $2,548 |
| Jazz Pharmaceuticals Inc. | 52 | $1,875 |
| Otter Pharmaceuticals, LLC | 1 | $1,338 |
| Neurelis, Inc. | 58 | $811 |
| Livanova USA, Inc. | 17 | $464 |
| Sumitomo Pharma America, Inc. | 15 | $368 |
| Corium, LLC | 13 | $300 |
| Ironshore Pharmaceuticals Inc. | 15 | $243 |
| Immedica Pharma US, Inc. | 6 | $140 |
| Greenwich Biosciences, Inc. | 7 | $131 |
| Biocodex, Inc. | 4 | $127 |
| Aprecia Pharmaceuticals, LLC | 7 | $113 |
| Biogen | 5 | $110 |
| Tris Pharma Inc | 6 | $82 |
| Zogenix Inc. | 2 | $49 |
| Aucta Pharmaceuticals, Inc. | 2 | $47 |
| Novartis | 3 | $45 |
| NS Pharma, Inc. | 2 | $29 |
| AbbVie | 1 | $28 |
| Vertical Pharmaceuticals, LLC | 2 | $27 |
| Acadia Pharmaceuticals Inc | 1 | $26 |
| Ipsen Biopharmaceuticals, Inc | 1 | $16 |
| Piramal Critical Care | 1 | $13 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$229,588 in reported general payments places this provider in the 95th percentile of 137 neurology with special qualifications in child neurology providers in Florida.
See all neurology with special qualifications in child neurology providers in Florida →
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Lacosamide | 12 | $914 |
Paid to pharmacies, not to this prescriber.
Other neurology with special qualifications in child neurology in Miami
- Migvis MonduyMiami$188K
- Elza VasconcellosMiami$170K
- Ian MillerMiami$104K
- Matt LallasMiami$88K
- Marytery FajardoMiami$44K
- Paula SchleiferMiami$31K
- Roberto Lopez-AlberolaMiami$31K
- Anuj JayakarMiami$24K
- Walter BradleyMiami$19K
- Yashira Torres RamirezMiami$18K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.